{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:36Z","timestamp":1791286956929,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.1093\/infdis\/jir122","type":"journal-article","created":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T05:37:29Z","timestamp":1305697049000},"page":"1556-1564","source":"Crossref","is-referenced-by-count":102,"title":["A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans"],"prefix":"10.1093","volume":"203","author":[{"given":"Klaus K.","family":"Orlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Hofmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg W.","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko G.","family":"Falkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Loew-Baselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Poellabauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut J.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Noel","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"key\n\t\t\t\t20170702133543_bib1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"key\n\t\t\t\t20170702133543_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21","author":"Suss","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/B978-1-4160-3611-1.50036-2","article-title":"Tick-borne encephalitis virus vaccines","volume-title":"Vaccines","author":"Barrett","year":"2008","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702133543_bib4","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","article-title":"Tick-borne encephalitis virus: a review of an emerging zoonosis","volume":"90","author":"Mansfield","year":"2009","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702133543_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.26.18916-en","article-title":"Tick-borne encephalitis in Europe and beyond: the epidemiological situation as of 2007","volume":"13","author":"Suss","year":"2008","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170702133543_bib6","first-page":"1153","volume-title":"Fields Virology","author":"Gubler","year":"2007","edition":"5th ed."},{"key":"key\n\t\t\t\t20170702133543_bib7","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1099\/vir.0.023663-0","article-title":"Tick-borne encephalitis virus in ticks in Finland, Russian Karelia, and Buryatia","volume":"91","author":"Jaaskelainen","year":"2010","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20170702133543_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3201\/eid1210.060320","article-title":"Siberian subtype tickborne encephalitis virus, Finland","volume":"12","author":"Jaaskelainen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0264-410X(98)00360-0","article-title":"Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization","volume":"17","author":"Chiba","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib10","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/S0264-410X(01)00218-3","article-title":"Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and Far-Eastern subtype strains","volume":"19","author":"Hayasaka","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0264-410X(91)90157-2","article-title":"Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine","volume":"9","author":"Klockmann","year":"1991","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2006.09.014","article-title":"Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus","volume":"25","author":"Leonova","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib13","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1016\/j.vaccine.2010.02.092","article-title":"An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system","volume":"28","author":"Orlinger","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib14","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702133543_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijmm.2006.01.019","article-title":"Immunogenicity and safety of FSME-IMMUN 0.5ml using a rapid immunization schedule","volume":"296","author":"Loew-Baselli","year":"2006","journal-title":"Int J Med Microbiol"},{"key":"key\n\t\t\t\t20170702133543_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JVI.74.1.24-32.2000","article-title":"Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production","volume":"74","author":"Lee","year":"2000","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib18","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","article-title":"Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM","volume":"72","author":"Stocks","year":"1998","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/519392","article-title":"West Nile virus neutralization by US plasma-derived immunoglobulin products","volume":"196","author":"Planitzer","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib20","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3201\/eid1510.081668","article-title":"West Nile virus infection in plasma of blood and plasma donors, United States","volume":"15","author":"Planitzer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib21","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1016\/j.vaccine.2010.07.027","article-title":"Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy","volume":"28","author":"Seidel","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib22","first-page":"29","article-title":"Epidemiology of West Nile in Europe and in the Mediterranean basin","volume":"4","author":"Calistri","year":"2010","journal-title":"Open Virol J"},{"issue":"10","key":"key\n\t\t\t\t20170702133543_bib23","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.10.19812-en","article-title":"Increasing West Nile Virus antibody titres in central European plasma donors from 2006 to 2010","volume":"16","author":"Rabel","year":"2011","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170702133543_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3201\/eid1003.020734","article-title":"Tick-borne encephalitis in southern Norway","volume":"10","author":"Csango","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib25","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib27","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib28","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20170702133543_bib30","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.71.4.2921-2927.1997","article-title":"Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib31","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JVI.72.4.3076-3081.1998","article-title":"Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein","volume":"72","author":"Kreil","year":"1998","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170702133543_bib33","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702133543_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0065-3527(03)61013-4","article-title":"Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis","volume":"61","author":"Lai","year":"2003","journal-title":"Adv Virus Res"},{"key":"key\n\t\t\t\t20170702133543_bib35","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702133543_bib36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/CVI.00095-09","article-title":"Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests","volume":"16","author":"Johnson","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702133543_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00220-08","article-title":"Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera","volume":"16","author":"Komar","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702133543_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4269\/ajtmh.2004.71.639","article-title":"Construction of yellow fever\/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool","volume":"71","author":"Pugachev","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702133543_bib39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702133543_bib40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","article-title":"Development of a mammalian cell (Vero) derived candidate influenza virus vaccine","volume":"16","author":"Kistner","year":"1998","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702133543_bib41","first-page":"55","article-title":"The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine","volume":"47","author":"Montagnon","year":"1981","journal-title":"Dev Biol Stand"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/203\/11\/1556\/18063837\/jir122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T11:19:52Z","timestamp":1637666392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir122","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}